Booster COVID jab may be crucial with new COVID-19 variants emerging

INDIA – With the pandemic still far from over and mutations of the virus still expected to emerge in the near future, a need for a booster dose of the second generation COVID-19 vaccination might be adopted. The chief of All India Institute of Medical Science (AIIMS), Dr Randeep Guleria has called for the need of India to adopt a second-generation booster jab as he believes that the human immunity tends to fall as time progresses. The second- generation vaccines were developed to protect the population from the new emerging…

Read More

Covaxin trials now set to be conducted on children across six hospitals as also Glenmark plans to roll out its phase 3 trials of its nasal COVID-19 treatment

INDIA – The Indian government is aggressively trying to curb the COVID -19 pandemic with the roll out of various programs across the state. Currently the state has embarked on two programs in a bid to curb the spread of the virus with the first one being conducting vaccine trials on children (Covaxin trials) and the second one involving phase 3 trials of a nasal therapy meant to cure COVID-19 symptoms. The Covaxin trials will be conducted on 175 children aged 2-6, 6-12 and 12-18 who will be given the…

Read More

Breakthrough as phase 1 clinical malaria vaccine trial results come positive with proof to give strong lasting protection against malaria

US – The National Institute of Allergy and Infectious Diseases’ (NIAID) phase 1 clinical trials of its malaria vaccine, Sanaria (PfSPZ), have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. Trials were conducted at the National Institutes of Health (NIH) Clinical Centre in Bethesda, Maryland led by Patrick E. Duffy, M.D., of the NIH National Institute of Allergy and Infectious Diseases (NIAID), and Stephen L. Hoffman, M.D., CEO of Sanaria Inc., Rockville, Maryland. In the CVac trials, healthy…

Read More

Students pursuing higher education in Karnataka, India to get the COVID-19 vaccine jab

INDIA – According to the Indian health minister, 24,37,732 students pursuing higher studies in Karnataka state will get vaccinated in a vaccination program that is already running. The vaccination program is also targeting children below the age of ten based on priority with parents being encouraged to take their children for the jab. The vaccine supply has been increased to make it possible with India currently administering two locally made vaccines, covishield and covaxin. Serum Institute of India (SII) makes Covishield (under license from AstraZeneca), whilst the second largest producer,…

Read More

Bharat Biotech’s covaxin inches closer to the WHO’s emergency use listing

INDIA – Following an acceptance of its expression of interest by World Health Organization (WHO), Bharat’s covaxin could make it to the emergency use listing (EUL) after providing WHO with additional data. Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities and is the brainchild behind covaxin among numerous drugs. The pre-submission meeting of the vaccine maker with WHO has been planned in reference to the WHO EUL guidance document that was uploaded on the WHO website. A WHO EUL would open doors of…

Read More

FDA says no new Emergency Use Authorization will be approved for COVID vaccines

INDIA – Soon after Ocugen hit a major bump after FDA rejected emergency use authorisation (EUA) for Covaxin, Hyderabad-based Bharat Biotech has said that the USFDA had earlier communicated that no new Emergency Use Authorization (EUA) will be approved for Covid vaccines. The Pennsylvania-based eye disease company has had to change its application from an Emergency Use Authorization to a full Biologics License Applications (BLA) approval. Bharat Biotech said biological license application process is the standard process for vaccines This is setback that will potentially delay the launch of Bharat…

Read More